WU Hongji,GAO Min,XU Yan,et al.DING Ying's Clinical Experience in Treating Systemic Lupus Erythematosus Based on Differentiation of Yin Fire,Latent Fire,and Fire Toxin[J].Journal of Traditional Chinese Medicine,2026,67(04):365-369.
WU Hongji,GAO Min,XU Yan,et al.DING Ying's Clinical Experience in Treating Systemic Lupus Erythematosus Based on Differentiation of Yin Fire,Latent Fire,and Fire Toxin[J].Journal of Traditional Chinese Medicine,2026,67(04):365-369.DOI: 10.13288/j.11-2166/r.2026.04.004.
DING Ying's Clinical Experience in Treating Systemic Lupus Erythematosus Based on Differentiation of Yin Fire,Latent Fire,and Fire Toxin
This paper summarizes Professor DING Ying's clinical experience in the treatment of systemic lupus erythematosus (SLE) through differentiation of three states,
yin
fire, latent fire, and fire toxin. It is proposed that fire pathogenic factors constitute a key pathological element running throughout the entire disease course of SLE. The evolution of its pathogenesis centers on these three states, spleen-kidney deficiency with the initial emergence of
yin
fire as the onset of disea
se, damage to
yin
by medicinal toxicity with internal blazing of latent fire as the driver of disease progression, and the interlocking of blood stasis and heat with intense scorching by fire toxin as the critical factor leading to severe and life-threatening conditions. Corresponding to these three stages, targeted prescriptions are formulated,
Jiuwei Yishen Formulation
(九味益肾方) to tonify the spleen and kidney, raise
yang
, and disperse fire;
Ziyin Xiehuo Decoction
(滋阴泄火汤) to nourish
yin
and fluids while clearing latent fire; and
Santeng Changluo Jiedu Decoction
(三藤畅络解毒汤) to dispel blood stasis, unblock the collaterals, detoxify, and restrain fire. This staged and integrated therapeutic strategy aims to address both root and branch and to achieve overall regulation, providing valuable guidance for the clinical differentiation and treatment of SLE.
关键词
Keywords
references
FANOURIAKIS A , KOSTOPOULOU M , ANDERSEN J , et al . EULAR recommendations for the management of systemic lupus erythematosus: 2023 update [J]. Ann Rheum Dis , 2024 , 83 ( 1 ): 15 - 29 .
BARBER MRW , DRENKARD C , FALASINNU T , et al . Global epidemiology of systemic lupus erythematosus [J]. Nat Rev Rheumatol , 2021 , 17 ( 9 ): 515 - 532 .
HOI A , IGEL T , MOK CC , et al . Systemic lupus erythematosus [J]. Lancet Lond Engl , 2024 , 403 ( 10441 ): 2326 - 2338 .
LU Fang's Clinical Experience in Differentiation and Treatment of Systemic Lupus Erythematosus from the Perspective of Heat-Toxin and Blood-Stasis in the Collaterals
DING Ying's Experience in Treating Children with IgA Nephropathy from the Perspective of "Wind-Induced Water Turbidity"
The Experience of AI Rudi in Staged Differentiation and Treatment of Systemic Lupus Erythematosus
Professor DING Ying's Experience in the Treatment of Chronic Immune Thrombocytopenia in Children by Nourishing Blood and Tranquilizing Collaterals
Clinical Experience of Professor CUI Yinglin in Treating Pediatric Mitochondrial Encephalomyopathy Based on the Original Qi Theory
Related Author
NIU Yingchao
PIAO Yongzhu
GENG Xiang
GAO Zhihui
ZHANG Yan
WU Huibin
WANG Zhilong
GE Shuangshuang
Related Institution
Heilongjiang University of Chinese Medicine
First Affiliated Hospital,Heilongjiang University of Chinese Medicine
哈尔滨市中医医院
Pediatric Hospital of the First Affiliated Hospital of Henan University of Chinese Medicine
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine